Neuronetics Announces Launch of Underwritten Public Offering of Common Stock
(NASDAQ: STIM) (the “Company”) today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, the Company expects to grant the underwriter ...
Globus Medical to buy Nevro in $250M all-cash deal
Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.
Tesla is an AI company now
Tesla has long been focused on automation, continually promising that unsupervised self-driving will come “soon,” a refrain ...
Neuphoria Therapeutics price target raised to $21 from $8 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Neuphoria Therapeutics (NEUP) to $21 from $8 and keeps a Buy rating on the shares. The firm ...
Watch These Nvidia Stock Price Levels Amid Continued Slump for AI Favorite
Nvidia shares fell Monday after the Trump administration said it would impose tariffs, adding to steep losses for the stock that were fueled by concerns related to the success of Chinese startup ...
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval
Key Takeaways Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration.The drugmaker said the twice-daily pill, Journavx, is the first such treatment to ...